Skip to main content

Table 2 Details of age categories

From: Relative risk of renal disease among people living with HIV: a systematic review and meta-analysis

Study name Study type Period Disease Location study size Follow up Age (group 1) years Age(group 2)years RR 95%
Campbell, 2009 [10] cross-sectional 1998-2005 CKD BT, UK 3439 -- > = 50 (Indinavir) < 50 4.92 1.31, 18.4
Campbell, 2009 [10] cross-sectional 1998-2005 CKD UK 3439 -- > = 50 (Tenofovir) < 50 5.42 1.71, 16.8
Crane, 2007 [4] Cohort 2001-2006 Kidney dysfunction WA, USA 445 -- 30-40 < 30 0.90 0.2, 3.2
Crane, 2007 [4] Cohort 2001-2006 Kidney dysfunction USA 445 -- 40-50 < 30 2.10 0.6, 7.6
Crane, 2007 [4] Cohort 2001-2006 Kidney dysfunction USA 445 -- > 50 < 40 4.40 1.1, 17.2
Franey, 2009 [13] Cohort 2004-2007 RI South Africa 2189 -- > 40 < 30 4.65 3.54, 6.10
Ganesan, 2010 [14] Cohort 1986-2008 CKD USA 4044 6.5 > = 35 < 35 2.6 1.7, 4.0
Lucas, 2007 [20] Cohort 1988-2004 CKD MD, USA 4509 4.6 30-49.9 < 30 1.50 0.7, 3.3
Lucas, 2007 [20] Cohort 1988-2004 CKD USA 4509 4.6 > = 50 < 50 2.00 0.8, 4.7